Tag - Ester Hong

Janney Montgomery Scott launched coverage of Baudax Bio (NASDAQ:BXRX) with a “buy” rating and fair value estimate of $12. The stock closed at $4.51 on Nov. 21. Baudax was spun out of Recro Pharma (NASDAQ:REPH) in a...